Trxade Group, Inc. Gains 41.28%
![Trxade Group, Inc. Gains 41.28%](https://stocktreats.com/storage/quote/73988-KB65oqJE/website-screenshot.jpg)
Trxade Group, Inc. (MEDS:NASDAQ) soared at $9.24, a gain of 41.3%. On Mon, Jun 17, 2024, MEDS:NASDAQ touched a New 2-Week High of $9.24. The stock appeared on our News Catalysts scanner on Wed, May 29, 2024 at 07:17 PM in the 'EARNINGS' category. From Mon, Jun 03, 2024, the stock recorded 40.00% Up Days and 54.55% Green Days
About Trxade Group, Inc. (MEDS:NASDAQ)
Trxade Group Inc engages in designing and developing business to business web-based platform which provides buying and selling opportunities for pharmacies and national suppliers of the pharmaceutical industry. The products developed by the company are trxade.com which is a web-based pharmaceutical platform for promoting and trade among independent pharmacies and suppliers, inventoryrx.com which is also a platform for promoting and trading among suppliers and manufacturers nationally, pharmabayonline which provides access to pharmaceutical data analytics to United States based independent pharmacies, and rxguru which is a service based desktop software applications for providing drug pricing and analytics.
Top 10 Gainers:
- Mustang Bio, Inc. (MBIO:NASDAQ), 476.92%
- Movella Holdings Inc Com (MVLA:NASDAQ), 75.83%
- Interactive Strength Inc. (TRNR:NASDAQ), 71.33%
- Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI:NASDAQ), 60.46%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 60%
- Azitra Inc (AZTR:NYSEMKT), 56.53%
- Unico American Corporation (UNAM:NASDAQ), 50%
- Trxade Group, Inc. (MEDS:NASDAQ), 41.28%
- Xponential Fitness Inc. Class A (XPOF:NYSE), 34.25%
- ENDRA Life Sciences Inc. (NDRA:NASDAQ), 34.17%